Estimation of human exposure to natural radionuclides using in vivo skull measurements.

Radiat Prot Dosimetry

STUK-Radiation and Nuclear Safety Authority, P.O. Box 14, FIN-00881 Helsinki, Finland.

Published: December 2003

In a preliminary study, in vivo skull measurements and in vitro urine measurements of 210Pb and nulU have been performed to find out the individual, chronic exposure to waterborne natural radionuclides of a small group of Finnish people. For their domestic water, the studied individuals use water from drilled wells containing elevated concentrations of natural uranium and its daughter nuclides ((234,235,238)U, 222Rn, (226,228)Ra, 210Po, 210Pb). Enhanced 210Pb and 235U activities were observed in several people. A positive correlation is observed between the U concentration in urine (microg d(-1)) and the number of counts (cpm) in the gamma ray energy peaks originating from the decay of 235U and 234Th respectively. Calibration of the detector set-up and the determination of background sources are in progress.

Download full-text PDF

Source
http://dx.doi.org/10.1093/oxfordjournals.rpd.a006313DOI Listing

Publication Analysis

Top Keywords

natural radionuclides
8
vivo skull
8
skull measurements
8
estimation human
4
human exposure
4
exposure natural
4
radionuclides vivo
4
measurements preliminary
4
preliminary study
4
study vivo
4

Similar Publications

Article Synopsis
  • The study investigates uranium (U/U) ratios in environmental samples from the Pamir region to evaluate the influence of human nuclear activity on this remote area.
  • The U/U ratios found (ranging from 0.007256 to 0.007263) suggest a slight enrichment of uranium, indicating the presence of anthropogenic materials, particularly in cryoconite compared to soil and water.
  • The findings also suggest that while the area shows subtle enrichment of uranium, it remains relatively clean from local contamination, with environmental uranium largely resulting from historical global nuclear fallout rather than local sources.
View Article and Find Full Text PDF

Chronic Radium-226 Bioaccumulation and Toxicity in the Aquatic Invertebrate Daphnia magna.

Arch Environ Contam Toxicol

January 2025

Toxicology Centre, University of Saskatchewan, 44 Campus Drive, Saskatoon, SK, S7N 5B3, Canada.

Mining operations in Canada, including uranium mining and milling, generate by-products containing radionuclides, including radium-226 (Ra), a long-lived, bioaccumulative calcium (Ca) analog. Despite strict discharge regulations, there is limited evidence to suggest that current thresholds for Ra adequately protect aquatic organisms. Furthermore, Canada lacks a federal water quality guideline for Ra, underscoring the need for protective limits to safeguard aquatic ecosystems.

View Article and Find Full Text PDF

Tracing ancient solar cycles with tree rings and radiocarbon in the first millennium BCE.

Nat Commun

January 2025

Laboratory of Ion Beam Physics, ETH Zurich, Otto-Stern Weg 5 HPK, 8093, Zurich, Switzerland.

The Sun drives Earth's energy systems, influencing weather, ocean currents, and agricultural productivity. Understanding solar variability is critical, but direct observations are limited to 400 years of sunspot records. To extend this timeline, cosmic ray-produced radionuclides like C in tree-rings provide invaluable insights.

View Article and Find Full Text PDF

Gastrin-releasing peptide receptors (GRPRs) overexpressed in many cancers are known as promising biomarkers to target tumors such as prostate, breast, and lung cancers. As the early diagnosis of the cancers can serve for better treatment of the patients, [In]In-DOTA-Pip-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2 ([In]In-RM2) was prepared using an in-house developed Sn/In generator. 0.

View Article and Find Full Text PDF

Innovative payloads for ADCs in cancer treatment: moving beyond the selective delivery of chemotherapy.

Ther Adv Med Oncol

January 2025

Division of New Drugs and Early Drug Development, European Institute of Oncology, IRCCS, Via Giuseppe Ripamonti 435, Milan 20141, Italy.

Antibody-drug conjugates (ADCs) have emerged as a transformative approach in cancer therapy by enhancing tumor targeting and minimizing systemic toxicity compared to traditional chemotherapy. Initially developed with chemotherapy agents as payloads, ADCs have now incorporated alternative payloads, such as immune-stimulating agents, natural toxins, and radionuclides, to improve therapeutic efficacy and specificity. A significant advancement in ADC technology is the integration of Proteolysis Targeting Chimeras (PROTACs), which enable the precise degradation of cellular targets involved in tumorigenesis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!